片仔癀(600436.SH)拟参与竞买华润片仔癀药业51%股权
格隆汇6月28日丨片仔癀(600436.SH)公布,公司拟参与竞买华润医药集团有限公司(“华润医药”、“转让方”)在上海联合产权交易所公开挂牌转让的其持有的华润片仔癀药业有限公司(“标的公司”)51%股权,转让底价约1.66亿元。
公司董事会授权给经营管理层在董事会决策权限范围内的价格参与竞买标的公司股权的具体实施事项以及签署此次竞买事项相关的法律文件或合同。
如公司竞买成功,公司将持有标的公司100%的股权。如第三方竞买成功,除此次交易已公开披露的各事项外,公司将就标的公司后续生产、经营等安排与标的公司进行重新协商,最终以正式签署的合作协议为准。
截止至2018年6月30日,标的公司的净资产评估增值3366.69万元,主要原因系无形资产(即:心舒宝片、复方片仔癀含片、茵胆平肝胶囊、护肝片、复方片仔癀软膏、复方片仔癀痔疮软膏、片仔癀润喉糖等7项产品的发明专利及外观设计等)评估增值6634.12万元所致。
如公司竞买成功,此次交易有利于公司致力于主营业务发展和核心竞争能力的提高,完善普药业务的规划布局,对公司及标的公司的财务状况和经营成果在短期内无重大影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.